We demonstrated that NOTCH1-mutated CLL cells are characterized by lower CD20 expression [128,134,175] and lower sensitivity to rituximab-mediated complement-mediated cytotoxicity [134]. The gene discussed is MS4A1; the disease is B-cell chronic lymphocytic leukemia.